Wockhardt Bilan de santé
Santé financière contrôle des critères 4/6
Wockhardt has a total shareholder equity of ₹36.6B and total debt of ₹23.6B, which brings its debt-to-equity ratio to 64.3%. Its total assets and total liabilities are ₹76.5B and ₹39.9B respectively. Wockhardt's EBIT is ₹540.0M making its interest coverage ratio 0.2. It has cash and short-term investments of ₹5.2B.
Informations clés
64.3%
Ratio d'endettement
₹23.56b
Dette
| Ratio de couverture des intérêts | 0.2x |
| Argent liquide | ₹5.23b |
| Fonds propres | ₹36.62b |
| Total du passif | ₹39.87b |
| Total des actifs | ₹76.49b |
Mises à jour récentes de la santé financière
Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jul 27
Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Recent updates
Wockhardt Limited's (NSE:WOCKPHARMA) Shares Climb 29% But Its Business Is Yet to Catch Up
Nov 02What Wockhardt Limited's (NSE:WOCKPHARMA) 27% Share Price Gain Is Not Telling You
Aug 20Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jul 27Wockhardt Limited (NSE:WOCKPHARMA) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
Jun 30Shareholders Will Probably Not Have Any Issues With Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation
Jun 22Subdued Growth No Barrier To Wockhardt Limited (NSE:WOCKPHARMA) With Shares Advancing 29%
Feb 21There's Reason For Concern Over Wockhardt Limited's (NSE:WOCKPHARMA) Massive 28% Price Jump
Dec 19There's No Escaping Wockhardt Limited's (NSE:WOCKPHARMA) Muted Revenues
Oct 14Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?
Jun 23Estimating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Feb 18Wockhardt (NSE:WOCKPHARMA) Is Making Moderate Use Of Debt
Jan 04Shareholders Will Probably Hold Off On Increasing Wockhardt Limited's (NSE:WOCKPHARMA) CEO Compensation For The Time Being
Jul 26Calculating The Intrinsic Value Of Wockhardt Limited (NSE:WOCKPHARMA)
May 18Calculating The Fair Value Of Wockhardt Limited (NSE:WOCKPHARMA)
Jan 26
What Did Wockhardt's (NSE:WOCKPHARMA) CEO Take Home Last Year?
Dec 01Analyse de la situation financière
Passif à court terme: WOCKPHARMA's short term assets (₹21.8B) do not cover its short term liabilities (₹27.9B).
Passif à long terme: WOCKPHARMA's short term assets (₹21.8B) exceed its long term liabilities (₹12.0B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: WOCKPHARMA's net debt to equity ratio (50.1%) is considered high.
Réduire la dette: WOCKPHARMA's debt to equity ratio has reduced from 112.3% to 64.3% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: Whilst unprofitable WOCKPHARMA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Prévisions de trésorerie: WOCKPHARMA is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 18.3% per year.